×
About 1,193 results

ALLMedicine™ Anticoagulation Center

Research & Reviews  427 results

FlowTriever Retrieval System for the treatment of pulmonary embolism: overview of its s...
https://doi.org/10.1080/17434440.2021.1982379
Expert Review of Medical Devices; Bishay VL, Adenikinju O et. al.

Sep 18th, 2021 - Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. There has been little change in PE mortality rates over the past two decades making this an appealing area for innovation and development.Areas Covered: While anticoag...

Clinical efficacy of regional citrate anticoagulation in continuous renal replacement t...
https://doi.org/10.21037/apm-21-1693
Annals of Palliative Medicine; Chang H, Gong Y et. al.

Sep 8th, 2021 - A systematic review and meta-analysis were conducted to explore the clinical efficacy and coagulation function of regional citrate anticoagulation (RCA) in continuous renal replacement therapy (CRRT) in critically ill patients, to provide an effec...

Anticoagulant effect of low concentration plasma trisodium citrate in continuous veno-v...
https://doi.org/10.21037/apm-21-1672
Annals of Palliative Medicine; Long J, Li Z et. al.

Sep 8th, 2021 - Effective anticoagulation is a prerequisite of continuous renal replacement therapy (CRRT). During CRRT, prolonged anticoagulant therapy should be administered to prevent extracorporeal clotting. The purpose of our study was to evaluate whether a ...

Comparison of Anticoagulation Regimens Following Stent Placement for Nonthrombotic Lowe...
https://doi.org/10.1016/j.jvir.2021.08.016
Journal of Vascular and Interventional Radiology : JVIR; Arendt VA, Mabud TS et. al.

Sep 4th, 2021 - To determine whether sub-therapeutic anticoagulation regimens are non-inferior to therapeutic anticoagulation regimens following stent placement for nonthrombotic lower extremity venous disease. Fifty-one consecutive patients (88% female, mean age...

see more →

Drugs  1 results see all →

News  49 results

Are Left Atrial Thrombi That Defy Preprocedure Anticoagulation Predictable?
https://www.medscape.com/viewarticle/952793

Jun 9th, 2021 - Three or more weeks of oral anticoagulation (OAC) sometimes isn't up to the job of clearing any potentially embolic left atrial (LA) thrombi before procedures like cardioversion or catheter ablation in patients with atrial fibrillation (AF). Such ...

Modest Clinical Gain for AF Screening of Asymptomatic Elderly: STROKESTOP
https://www.medscape.com/viewarticle/949950

Apr 26th, 2021 - Some, perhaps many, previously unrecognized cases of atrial fibrillation (AF) will come to light in a screening program aimed at older asymptomatic adults. The key question is whether the challenges of such systematic but age-restricted AF screeni...

Parity Whether Anticoagulation Is Halted or Not for Unplanned Cath
https://www.medscape.com/viewarticle/949064

Apr 9th, 2021 - Maintaining oral anticoagulation (OAC) throughout an unplanned cardiac catheterization confers no extra risk and might hold some advantages over periprocedural OAC interruption in patients on long-term anticoagulation therapy, suggests a major reg...

Left Atrial Appendage Occlusion, DOAC Comparable for AFib
https://www.medscape.com/viewarticle/944133

Jan 14th, 2021 - Left atrial appendage occlusion (LAAO) for high-risk atrial fibrillation seems to prevent stroke as well as direct oral anticoagulation (DOAC) with a lower risk of major bleeding, according to results of a European study. And although some experts...

'Low-Risk' Valvular AF in Some May be Risky Enough for Oral Anticoagulation
https://www.medscape.com/viewarticle/937294

Sep 11th, 2020 - Some patients with "valvular" atrial fibrillation (AF) and stroke-risk scores low enough for oral anticoagulation (OAC) not to be indicated may actually face enough thromboembolic risk to justify the lifelong therapy, a new report suggests. The co...

see more →